SRS Capital Advisors »

Neuropace shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.9k 122 15.89

More positions owned by SRS Capital Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Comfort Systems USA (FIX)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Index Fds Value Etf (VTV)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for SRS Capital Advisors

Top funds holding Neuropace

Polar Capital Holdings
Soleus Capital Management
First Light Asset Management
Morgan Stanley
BlackRock
OrbiMed Advisors
Driehaus Capital Management
Vanguard Capital Management
Deutsche Bank Aktiengesellschaft
Armistice Capital
Geode Capital Management
FMR
State Street Corporation
Silvercrest Asset Management Group
Northern Trust

View all funds holding Neuropace